Brief: Dianthus Therapeutics Announces Pricing Of Upsized $251 Million Underwritten Public Offering
10/09/2025 03:37
Sept 9 (Reuters) - Dianthus Therapeutics Inc DNTH.O: DIANTHUS THERAPEUTICS, INC. ANNOUNCES PRICING OF UPSIZED $251 MILLION UNDERWRITTEN PUBLIC OFFERING DIANTHUS THERAPEUTICS INC - PRICES UPSIZED PUBLIC OFFERING AT $33 PER SHARE Source text: ID:nGNXb86Gmn Further company coverage: DNTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dianthus Therapeutics
See all newsU.S. RESEARCH ROUNDUP- Adobe, Chewy, Mosaic
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Q2 net loss widens as R&D costs rise